Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Feb;77(1):55-61.
doi: 10.4103/0250-474x.151601.

Bioadhesive films containing fluconazole for mucocutaneous candidiasis

Affiliations

Bioadhesive films containing fluconazole for mucocutaneous candidiasis

S K Patel et al. Indian J Pharm Sci. 2015 Jan-Feb.

Abstract

Fluconazole is a broad spectrum antifungal agent that has been extensively applied for the management of oral, pharyngeal and cutaneous candidiasis. Fluconazole has a high volume of distribution (0.55-0.65 l/kg) and has systemic toxicity due to high drug-drug interaction. The present study focuses on the formulation of bioadhesive film as a controlled release carrier for fluconazole. The formulation was intended to provide localized delivery of fluconazole exclusively at the site of infection, thereby reducing its total dose and hence, dose-related toxicities. Bioadhesive films were prepared by solvent casting method using sodium alginate and polyvinyl alcohol alone as well as in various combinations. Prepared films were evaluated for physical characteristics like, weight and content uniformity, film thickness, swelling index, microenvironment pH and folding endurance. In vitro drug release, in vitro and ex vivo residence time, bioadhesive strength and skin irritation were also studied. Accelerated stability study was conducted on the optimized formulation as per ICH guidelines. Weight of all the films were not more than 20 mg. Thickness of the films ranged between 0.09 to 0.15 mm whereas swelling indices showed a high extent of variation. Films composed of polyvinyl alcohol alone provided a swelling index of 6%. Bioadhesive strength was found to be more than 18 g. Microenvironment pH was near to 7.0 for most of the formulations. Ex vivo residence time of optimized batch was more than 5 h and it provided controlled drug release up to 8 h. As revealed in FT-IR and DSC studies, drug was found to be compatible with the excipients used in this study.

Keywords: Fluconzole; bioadhesive film; localized delivery; mucocutaneous candidiasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
DSC thermograms of FLZ and physical mixture of FLZ and polymers. Differential scanning calorimetry (DSC) thermograms of (a) pure fluconazole (FLZ) and (b) physical mixture of fluconazole and polymers.
Fig. 4
Fig. 4
Scanning electron microscopic image of optimized formulation F5.
None
None

Similar articles

Cited by

References

    1. Nairy HM, Charyulu NR, Shetty VA, Prabhakara P. A Pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis. Trials. 2011;12:12–99. - PMC - PubMed
    1. Murray PA, Koletar SL, Mallegol I, Wu J, Moskovitz BL. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clin Ther. 1997;19:471–80. - PubMed
    1. Bachhav YG, Patravale VB. Microemulsion-based Vaginal Gel of Fluconazole: Formulation, In vitro and In vivo Evaluation. Int J Pharm. 2009;365:175–9. - PubMed
    1. Meis J, Petrou M, Bille J, Ellis D, Gibbs D. A global evaluation of the susceptibility of candida species to fluconazole by disk diffusion. Diagn Microbiol Infect Dis. 2000;36:215–23. - PubMed
    1. Mohan H. 5th ed. New Delhi: Jaypee Brothers, Medical Publishers; 2005. Textbook of pathology; pp. 188–90.

LinkOut - more resources